Industry
C&EN Pharmaceuticals
C&EN weekly chemistry news quiz, August 28
Test your knowledge of our stories on polymyxins, critical mineral recovery, skeletal editing, and more
Industry headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Industry
C&EN Pharmaceuticals
Test your knowledge of our stories on polymyxins, critical mineral recovery, skeletal editing, and more
Industry P Patent Docs
By Kevin E. Noonan – In addition to Arbutus Biopharma and Genevant Sciences defending on appeal the District Court’s summary judgment decision in their favor, these plaintiffs filed their complaint against the Federal Government pursuant to 28 U.S.C. § 1498 for recompense before…
Industry C Cell Systems
Cheng and Gu et al. introduce PROFET, a framework that reconstructs continuous single-cell trajectories from sparse scRNA-seq time series. By combining particle-based gradient flows with neural force matching, PROFET accurately captures nonlinear cell-state dynamics and reveals h…
Industry
Bio.News
A Food and Drug Administration (FDA) pilot program to expedite approval of new drugs contains potentially impactful initiatives but risks adding burdens, says the […] The post BIO applauds efforts targeting early drug development efficiency, provides suggestions appeared first on…
Industry
MHRA
Wales’ connected health and life sciences ecosystem creates opportunities to support innovation from development through to adoption, helping new products reach patients while supporting investment and growth.
Industry
MHRA
While most patients implanted with these hip replacements have well-functioning hips and are unlikely to develop serious problems, a small number may develop issues.
Industry
C&EN Pharmaceuticals
Here’s what we’re watching in the chemical and pharmaceutical industries this week
Industry
C&EN Pharmaceuticals
The German start-up will target heart conditions by inhibiting the activity of specific histone deacetylases
Industry I In the Pipeline
I’m taking a summer break and will return to posting Monday, August 31.
Industry
C&EN Pharmaceuticals
2-aminobenzothiazoles can stop antimicrobial-resistant bacteria from activating their defenses. But the mechanism remains mysterious
Industry P Practical Fragments
RNA helicases present an intriguing but challenging opportunity for drug discovery. Their importance for cell growth makes them attractive cancer targets. But to function, they must undergo considerable conformational changes, and this dynamism makes it difficult to find hig…
Industry E EUCOPE
Location: Brussels, Belgium (On-site) Contract Type: Full-time Application Deadline: 3 September 2026 About Us EUCOPE – The European Confederation of Pharmaceutical Entrepreneurs – is growing! We represent innovative small and mid-sized pharmaceutical, biotech, and medical techno…
Industry C Cell Systems
Identifying genes whose expression is inherited across cell divisions has required multiple samples or lineage tracking. Ghosh et al. use random matrix theory to show that such memory genes leave a power-law signature in single-sample sequencing data and develop Power-Seek, an al…
Industry S SecureBio
Detection is only worthwhile if it’s fast enough to trigger an effective response. The OpenAI Foundation has granted SecureBio Detection $17.2M to work on this.
Industry
Drug Discovery and Development
The demand for peptide therapeutics has grown rapidly in recent years, as the success of GLP-1 drugs has catapulted them to the forefront of developers’ and sponsors’ minds. Although peptides still represent a relatively small share of FDA-approved therapeutics, they offer distin…
Industry S SecureBio
Since our March update, we've expanded our biosurveillance network, improved the sensitivity of our nasal swab monitoring program, and built new partnerships.
Industry T The Labs Report
Scientific leaps demand capabilities that today’s structure-prediction architectures cannot practically deliver. Working backward from those ambitions led us to LightFold, our new co-folding model.
Industry E EUCOPE
Global Pharma & Biotech Summit 10 -11 November 2026 In-Person & Digital | Convene 22 Bishopsgate, London, UK The Global Pharma and Biotech Summit, organised by the Financial Times, brings together the leaders, investors and policymakers shaping the next phase of li…
Industry
Drug Discovery and Development
2022 was a big year for layoffs in biopharma. So were the next three. Novartis, for instance, outlined plans to cut up to 8,000 jobs in 2022, after pharmaceutical industry job cuts jumped 280% in 2021. Biogen followed in 2023 with a “Fit for Growth” program that put roughly 1,000…
Industry I In the Pipeline
This is an interesting paper at the intersection of chemistry, botany, and environmental science, and I think it’s probably going to get a fair amount of attention in the press. Unfortunately, it’s also likely that some of the headlines around it are going to mangle the details,…
Industry P Patent Docs
By Kevin E. Noonan – The parties in the appeal of the District Court’s grant of summary judgment to Arbutus and Genevant over Moderna, holding Moderna liable for $1.3 billion in patent infringement damages, attracted a fair amount of amicus support. Although Plaintiffs Arbu…
Industry I In the Pipeline
Moderna and Merck have been working together for some years now on cancer therapies that would combine Merck’s Keytruda antibody with personalized mRNA immunotherapy from Moderna (update: in a therapy co-developed and co-owned by both companies). And that “personalized” is no fig…
Industry C Cell Systems
Eck, Moretti, Schlomann, et al. established technology for quantifying single-cell transcriptional dynamics in live zebrafish embryos via imaging. Applied to the vertebrate segmentation clock, this approach revealed that the smooth oscillations of transcription factors orchestrat…
Industry
Drug Discovery and Development
OpenAI’s first international hospital partnership is taking shape at a giant medical center where English is not the default language and where the electronic health record does not come from Epic, the dominant U.S. EHR vendor. That institution is Sheba Medical Center, the Israel…
Industry
C&EN Pharmaceuticals
Here’s what we’re watching in the chemical and pharmaceutical industries this week
Industry
Drug Discovery and Development
Antibody-drug conjugates (ADCs) have emerged as one of the busiest and most crowded niches within oncology, given their potential to use an antibody to ferry a potent cytotoxic payload toward tumor cells. The class now spans about 15 FDA-approved products, and the segment is grow…
Industry P Practical Fragments
Most methods to characterize protein-ligand binding interactions have drawbacks. Crystallography, obviously, requires your protein to crystallize, while NMR and cryo-EM both have size limitations and are resource-intensive. Hydrogen-deuterium exchange mass spectrometry (HDX-MS),…
Industry
LifeSciVC
By Alex Harding, Entrepreneur-in-Residence at Atlas Venture, as part of the From The Trenches feature of LifeSciVC What will and will not work to regain US strength in phase 1 clinical trials “I don’t know anyone who runs their phase The post Make US INDs Great Again appeared fir…
Industry C Cell Systems
Bocci et al. developed a computational method, scRICH, which leverages single-cell transcriptomics data to quantify cell-cell communication heterogeneity within cell populations. By integrating cell transition and gene regulatory network inference, scRICH identifies emerging patt…
Industry
C&EN Pharmaceuticals
Test your knowledge of our stories on molecular glues, PVC recycling, biotech, and more
Industry
Drug Discovery and Development
By one measure, Alphabet-controlled Isomorphic Labs would tower over every company on this list. The AI drug discovery company has raised $2.7 billion in external financing, including a $2.1 billion Series B announced in May. Its corporate structure, however, puts it outside our…
Industry
C&EN Pharmaceuticals
After legal challenges from physicians and states stalled past efforts, a new executive order calls for separating combined vaccines and replacing adjuvants
Industry
MHRA
Medicines and medical devices regulator issues health advice for teens off to university.
Industry I In the Pipeline
This is an Alzehimer’s therapy idea that will be something to watch, but I must say at the outset that I’m very much in the “Show Me” camp for now. Nature reports on a surgical procedure developed in China that claims to increase the lymphatic flow from the central nervous system…
Industry
C&EN Pharmaceuticals
The start-up joins the next-generation autoimmune therapy race with $65 million in early funding to move its lead candidate through clinical trials
Industry P Patent Docs
By Kevin E. Noonan – The parties in the appeal of the District Court’s grant of summary judgment to Arbutus and Genevant over Moderna, holding Moderna liable for $1.3 billion in patent infringement damages attracted a fair amount of amicus support. Although Plaintiffs Arbut…
Industry
C&EN Pharmaceuticals
But only a handful of these firms have the capacity to make antibody-drug conjugates start to finish
Industry P Practical Fragments
Protein tyrosine phosphatase 1B (PTP1B) is a long-standing target for diabetes and other diseases. But as we’ve written previously, it is challenging to drug due to its small and highly charged active site, which is conserved among phosphatases. In a new open-access Drug Design D…
Industry I In the Pipeline
Let’s talk a bit about the Executive Order on the administration of childhood vaccines. But let me make it clear up front: I am not going to do the president the favor of taking his arguments seriously and doing any sort of point-by-point refutation. That’s because the premise of…
Industry
C&EN Pharmaceuticals
Researchers identify a first-in-kind metabolically activated degrader that hints at a new class of protein-degrading drugs